今年政府工作报告提出:坚决守住人民群众生命健康的防线

2019-03-06 落楠 中国医药报

3月5日,十三届全国人大二次会议在京开幕。

3月5日,十三届全国人大二次会议在京开幕。国务院总理李克强向大会所作的政府工作报告指出,药品疫苗攸关生命安全,必须强化全程监管,对违法者要严惩不贷,对失职渎职者要严肃查办,坚决守住人民群众生命健康的防线。

在部署2019年工作时,政府工作报告提出,加快发展社会事业,更好保障和改善民生。基本民生投入确保只增不减。支持社会力量增加非基本公共服务供给,满足群众多层次、多样化需求。保障基本医疗卫生服务。加强重大疾病防治。要实施癌症防治行动,推进预防筛查、早诊早治和科研攻关,着力缓解民生的痛点。做好常见慢性病防治,把高血压糖尿病等门诊用药纳入医保报销。

政府工作报告明确,深化公立医院综合改革。促进社会办医。加快建立远程医疗服务体系,加强基层医护人员培养,提升分级诊疗和家庭医生签约服务质量。坚持预防为主,将新增基本公共卫生服务财政补助经费全部用于村和社区,务必让基层群众受益。加强妇幼保健服务。支持中医药事业传承创新发展。

政府工作报告指出,坚持创新引领发展,培育壮大新动能。促进新兴产业加快发展。深化大数据、人工智能等研发应用,培育新一代信息技术、高端装备、生物医药、新能源汽车、新材料等新兴产业集群,壮大数字经济。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2019154, encodeId=8fd7201915452, content=<a href='/topic/show?id=359f68922cd' target=_blank style='color:#2F92EE;'>#生命健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68922, encryptionId=359f68922cd, topicName=生命健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Tue Apr 30 17:49:00 CST 2019, time=2019-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046497, encodeId=9435204649e8f, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Mon Mar 11 14:49:00 CST 2019, time=2019-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449932, encodeId=5d5e1449932c6, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Fri Mar 08 02:49:00 CST 2019, time=2019-03-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2019154, encodeId=8fd7201915452, content=<a href='/topic/show?id=359f68922cd' target=_blank style='color:#2F92EE;'>#生命健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68922, encryptionId=359f68922cd, topicName=生命健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Tue Apr 30 17:49:00 CST 2019, time=2019-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046497, encodeId=9435204649e8f, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Mon Mar 11 14:49:00 CST 2019, time=2019-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449932, encodeId=5d5e1449932c6, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Fri Mar 08 02:49:00 CST 2019, time=2019-03-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2019154, encodeId=8fd7201915452, content=<a href='/topic/show?id=359f68922cd' target=_blank style='color:#2F92EE;'>#生命健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68922, encryptionId=359f68922cd, topicName=生命健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Tue Apr 30 17:49:00 CST 2019, time=2019-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046497, encodeId=9435204649e8f, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Mon Mar 11 14:49:00 CST 2019, time=2019-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449932, encodeId=5d5e1449932c6, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Fri Mar 08 02:49:00 CST 2019, time=2019-03-08, status=1, ipAttribution=)]